» Articles » PMID: 33929324

CD8 T Cell Self-tolerance Permits Responsiveness but Limits Tissue Damage

Overview
Journal Elife
Specialty Biology
Date 2021 Apr 30
PMID 33929324
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Self-specific CD8T cells can escape clonal deletion, but the properties and capabilities of such cells in a physiological setting are unclear. We characterized polyclonal CD8 T cells specific for the melanocyte antigen tyrosinase-related protein 2 (Trp2) in mice expressing or lacking this enzyme (due to deficiency in , which encodes Trp2). Phenotypic and gene expression profiles of pre-immune Trp2/K-specific cells were similar; the size of this population was only slightly reduced in wild-type (WT) compared to -deficient () mice. Despite comparable initial responses to Trp2 immunization, WT Trp2/K-specific cells showed blunted expansion and less readily differentiated into a CD25proliferative population. Functional self-tolerance clearly emerged when assessing immunopathology: adoptively transferred WT Trp2/K-specific cells mediated vitiligo much less efficiently. Hence, CD8 T cell self-specificity is poorly predicted by precursor frequency, phenotype, or even initial responsiveness, while deficient activation-induced CD25 expression and other gene expression characteristics may help to identify functionally tolerant cells.

Citing Articles

T Cell Resistance: On the Mechanisms of T Cell Non-activation.

Beckers D, Jainarayanan A, Dustin M, Capera J Immune Netw. 2025; 24(6):e42.

PMID: 39801736 PMC: 11711127. DOI: 10.4110/in.2024.24.e42.


The CD8 T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects.

Van Der Byl W, Nussing S, Peters T, Ahn A, Li H, Ledergor G Immunity. 2024; 57(6):1324-1344.e8.

PMID: 38776918 PMC: 11807353. DOI: 10.1016/j.immuni.2024.04.026.


Activated B-Cells enhance epitope spreading to support successful cancer immunotherapy.

Kellermann G, Leulliot N, Cherfils-Vicini J, Blaud M, Brest P Front Immunol. 2024; 15:1382236.

PMID: 38571942 PMC: 10989059. DOI: 10.3389/fimmu.2024.1382236.


Functional heterogeneity and adaptation of naive T cells in response to tonic TCR signals.

Eggert J, Au-Yeung B Curr Opin Immunol. 2021; 73:43-49.

PMID: 34653787 PMC: 8648992. DOI: 10.1016/j.coi.2021.09.007.


CD8 T cell self-tolerance permits responsiveness but limits tissue damage.

Truckenbrod E, Burrack K, Knutson T, Borges da Silva H, Block K, OFlanagan S Elife. 2021; 10.

PMID: 33929324 PMC: 8147182. DOI: 10.7554/eLife.65615.

References
1.
Rosenberg S . IL-2: the first effective immunotherapy for human cancer. J Immunol. 2014; 192(12):5451-8. PMC: 6293462. DOI: 10.4049/jimmunol.1490019. View

2.
Azzam H, Grinberg A, Lui K, Shen H, Shores E, Love P . CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med. 1998; 188(12):2301-11. PMC: 2212429. DOI: 10.1084/jem.188.12.2301. View

3.
Zehn D, Bevan M . T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity. 2006; 25(2):261-70. PMC: 2774714. DOI: 10.1016/j.immuni.2006.06.009. View

4.
Cho H, Celis E . Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects. Cancer Res. 2009; 69(23):9012-9. PMC: 2789207. DOI: 10.1158/0008-5472.CAN-09-2019. View

5.
Yu W, Jiang N, Ebert P, Kidd B, Muller S, Lund P . Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes. Immunity. 2015; 42(5):929-41. PMC: 4455602. DOI: 10.1016/j.immuni.2015.05.001. View